Momentum continues to swell in support of the Open COVID Pledge, with the announcement today by Amazon, Facebook, Hewlett Packard Enterprise, IBM, Microsoft, and Sandia National Laboratories, that they are pledging their patents to the public to freely use in support of solving the COVID-19 pandemic. Following in the footsteps of Intel, Fabricatorz Foundation, and…

You’ve heard the stories: engineers 3D printing face shields in their basements; do-it-yourself hobbyists sewing face masks; and fashion designers crafting personal protection gowns.  Globally, people are trying to help fill the medical supply gap caused by the COVID-19 pandemic through open-source medical hardware. It’s a heartwarming display of global ingenuity, innovation, and collaboration. In this…

Creative Commons has joined forces with other legal experts and leading scientists to offer a simple way for universities, companies, and other holders of intellectual property rights to support the development of medicines, test kits, vaccines, and other scientific discoveries related to COVID-19 for the duration of the pandemic. The Open COVID Pledge grants the…

The global health crisis is crystalizing the need for policies that support universal access to learning resources. The COVID-19 pandemic has wreaked havoc on over a billion learners’ lives—half of the world’s student population have seen their schools or universities close to slow the spread of the virus. As a result, many educational institutions are…

"The Chancellor Rishi Sunak visits a coronavirus testing laboratory in Leeds," by HM Treasury, licensed CC BY-NC-SA.

In response to the global health emergency caused by COVID-19, we’ve seen an array of organizations, publications, and governments make COVID-19 related research open access. For example, the U.S. National Library of Medicine recently released the COVID-19 Open Research Dataset (CORD-19)—a machine-readable coronavirus literature collection with over 29,000 articles available for text and data mining…

Over the weekend, news emerged that upset even the most ardent skeptics of open access. Under the headline, “Trump vs Berlin” the German newspaper Welt am Sonntag reported that President Trump offered $1 billion USD to the German biopharmaceutical company CureVac to secure their COVID-19 vaccine “only for the United States.” In response, Jens Spahn, the…

"Working from home," by Victoria Heath, CC BY.

Over the last few days, a growing number of organizations have shut down their offices and told employees to work from home in order to prevent the spread of COVID-19. Here at Creative Commons (CC), we’ve also taken necessary precautions such as postponing all work-related travel and canceling the in-person component of the annual CC…